Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism
Ana González-Cuello1, M Victoria Milanés, M Teresa Castells
1Department of Cellular and Molecular Pharmacology, University School of Medicine, Murcia, Spain.
Abstract:
We previously demonstrated that hyperactivity of cardiac noradrenergic pathways observed during morphine withdrawal is mediated by peripheral mechanisms. In the present study, naloxone methiodide (quaternary derivative of naloxone that does not cross the blood-brain barrier) and naloxone were administered to morphine-dependent rats and Fos immunostaining was used as a reflection of neuronal activity. Dependence on morphine was induced by 7-day chronic subcutaneous (s.c.) implantation of six morphine pellets (75 mg). Morphine withdrawal was precipitated by administration of naloxone methiodide (5 mg/kg, s.c.) or naloxone (5 mg/kg, s.c.) on day 8. Using immunohistochemical staining of Fos, present results indicate that the administration of naloxone methiodide or naloxone to morphine-dependent rats induced marked Fos immunoreactivity within the cardiomyocyte nuclei. Moreover, Western blot analysis revealed a peak expression of c-fos in the right and left ventricles after naloxone methiodide- or naloxone-precipitated withdrawal. In addition, in the hypothalamic paraventricular nucleus (PVN), Fos expression was increased after naloxone-but not after naloxone methiodide-administration to morphine-dependent rats. These results suggest that the activation of c-fos expression observed during morphine withdrawal in the heart is due to intrinsic mechanisms outside the central nervous system (CNS).
Insights
Morphine withdrawal activates cardiac cells via peripheral mechanisms, not the central nervous system. This study shows naloxone methiodide and naloxone trigger Fos expression in heart cells during withdrawal.
Area of Science:
- Neuroscience
- Cardiology
- Pharmacology
Background:
- Morphine withdrawal causes cardiac noradrenergic hyperactivity.
- Previous research indicated peripheral mechanisms mediate this hyperactivity.
Purpose of the Study:
- To investigate the role of peripheral mechanisms in morphine withdrawal-induced cardiac hyperactivity.
- To differentiate between central nervous system (CNS) and peripheral effects on cardiac c-fos expression during withdrawal.
Main Methods:
- Morphine dependence was induced in rats via subcutaneous pellets.
- Withdrawal was precipitated using naloxone methiodide (peripheral) or naloxone (central/peripheral).
- Fos immunostaining and Western blot analysis were used to assess neuronal and cellular activity in the heart and hypothalamus.
Main Results:
- Both naloxone methiodide and naloxone induced significant Fos immunoreactivity in cardiomyocyte nuclei.
- Peak c-fos expression was observed in ventricles during precipitated withdrawal.
- Naloxone, but not naloxone methiodide, increased Fos expression in the hypothalamic paraventricular nucleus (PVN).
Conclusions:
- Cardiac c-fos expression during morphine withdrawal is primarily mediated by intrinsic cardiac mechanisms, independent of the CNS.
- Peripheral pathways play a crucial role in the cardiac response to morphine withdrawal.
More Related Videos
05:44The c-FOS Protein Immunohistological Detection: A Useful Tool As a Marker of Central Pathways Involved in Specific Physiological Responses In Vivo and Ex Vivo
Published on: April 25, 2016
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Desensitization and Tachyphylaxis
Several...
Heart Failure Drugs: Inotropic Agents
